Comparing the Use of Dienogest and Combined Oral Contraceptive Pills (Microgynon) to Reduce the Risk of Recurrence of Endometriotic Cyst After Conservative Surgery
Launched by THE UNIVERSITY OF HONG KONG · Mar 10, 2015
Trial Information
Current as of April 24, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Good general health
- • Older than the age of legal consent (i.e. 18 years old)
- • Sonographic diagnosis of ovarian endometrioma with diameter at least 4cm on 2 separate scans at least 6 weeks apart
- • No contraindication to use of progesterone or combined oral contraceptive pills
- • Not attempting to conceive either at the time of study entry or for at least 2 years after surgery
- • Willing and able to participate after the study has been explained
- Exclusion Criteria:
- • Operative findings not suggestive of endometriotic cyst
- • Contraindications to progestogens or oral contraceptive pills
- • Unwillingness to tolerate menstrual irregularity
- • Planning pregnancy within 2 years of study
- • Cannot understand English, Cantonese or Putonghua
Trial Officials
Jennifer K.Y. Ko, MBBS, MRCOG
Principal Investigator
The University of Hong Kong, Queen Mary Hospital
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
